• Product NameLGALS2 Antibody
• Host SpeciesRabbit
• ClonalityPolyclonal
• ApplicationsELISA WB IHC
• Species ReactivityHu Ms
• SpecificityThe antibody detects endogenous level of total LGALS2 protein.
• Immunogen TypeRecombinant protein
• Immunogen DescriptionFull length fusion protein
• Target NameLGALS2
• Alternative Names    ectin, galactoside-binding, soluble, 2, HL14
• Accession No. Swiss-Prot:P05162
  Gene ID:3957;
• UniprotP05162
• Gene ID3957;
• Formulation Rabbit IgG in pH7.4 PBS, 0.05% NaN3, 40% Glycerol.
• Storage Store at -20˚C/1 year

• Predicted MW: 15kd
  ELISA: 1:1000-1:5000
  Western blotting: 1:200-1:1000
  Immunohistochemistry: 1:10-1:50

The protein encoded by this gene is a soluble beta-galactoside binding lectin. The encoded protein is found as a homodimer and can bind to lymphotoxin-alpha. A single nucleotide polymorphism in an intron of this gene can alter the transcriptional level of the protein, with a resultant increased risk of myocardial infarction. This protein binds beta-galactoside. Its physiological function is not yet known.

• Gel: 15%+12%SDS-PAGE
  Lane1: Human liver Cancer tissue lysate
  Lane2: Human leiomyosarcoma tissue lysate
  Lysates: 40 ug per lane
  Primary antibody: 1/250 dilution
  Secondary antibody: Goat anti Rabbit IgG - H&L (HRP) at 1/10000 dilution
  Exposure time: 10 seconds
  
  
• The image on the left is immunohistochemistry of paraffin-embedded Human brain cancer tissue using 31075 (LGALS2 Antibody) at dilution 1/13, on the right is treated with the fusion protein.
  
  

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting